COVID-19 T-cell Data: Mapping out SARS-CoV-2 Antigen and T-cell Repertoires

What you will learn in this webinar

In partnership with Microsoft, Adaptive Biotechnologies has created a comprehensive and detailed open access database, ImmuneCODE, that provides COVID-19 data to accelerate ongoing efforts to develop better diagnostics, vaccines, and therapeutics for COVID-19. Here we will discuss the science behind the ImmuneCODE database presented in Nolan et al, some of the applications for which you can analyze the data, use of the immunoSEQ T-MAP COVID service, and initial data insights from the COVID-19 data described in Snyder et al.

1 - T cells in COVID-19 (Speaker Image) Patrick_Raber_Headshot_150

Patrick Raber Ph.D

Sr. Research & Business Development Manager

Dr. Patrick Raber is an immunologist with 12 years of research experience and is an expert in the field of immunosequencing. His current role as a Senior Manager of Research and Business Development at Adaptive is focused on the incorporation of immunosequencing into translational research and clinical trials for Adaptive’s academic and biopharmacuetical partners, with a focus on the key elements of experimental design, data analysis and data interpretation.

Open Speaker Bio
ThomasSnyderHeadshot-cropped-sq

Thomas Snyder, Ph.D

VP, Research, immunoSEQ Dx, Adaptive Biotechnologies

Thomas Snyder leads Adaptive’s scientific program, in collaboration with Microsoft, to map T-cell receptor sequences to the antigens they bind in order to create diagnostics for infectious disease, autoimmune diseases, and cancer.

Open Speaker Bio
Sean-Nolan

Sean Nolan

Distinguished
Engineer

Sean Nolan was CTO at Adaptive from 2014 through 2019. Now as Distinguished Engineer, Sean works on specialized projects primarily supporting internal and external research at Adaptive Biotechnologies.

Open Speaker Bio

Register for SEQdiscovery

To access these videos and all SEQdiscovery content.
If you have previously registered and opted to have an account please log in above.